Skip to main content

France Prohibits the Use of Macrolane in Aesthetic Breast Augmentation for Reasons Similar to Criticisms of Autologous Fat Grafting to the Breast

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Hedén P, Olenius M, Tengvar M (2011) Macrolane for breast enhancement: 12-month follow-up. Plast Reconstr Surg 127:850–860

    PubMed  Article  Google Scholar 

  2. 2.

    Décision de police sanitaire de l’AFSSAPS (2011) Portant restriction de la mise sur le marché et de l’utilisation des dispositifs médicaux injectables indiqués dans le comblement et l’augmentation des volumes corporels à visée esthétique, Saint- Denis, France.

  3. 3.

    Garrido I, Leguevaque P, Gangloff D, Mojallal A (2010) The adipose tissue transfer in the mammary parenchyma (part I): review of the literature on modifications of the radiological images. Ann Chir Plast Esthet 55:568–577

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Chaput B, De bonnecaze G, Tristant H, Garrido I, Grolleau JL, Chavoin JP (2011) Macrolane®: a too premature indication in breast augmentation: focusing on current knowledge of the product. Ann Chir Plast Esthet 56:17–171

    Article  Google Scholar 

  5. 5.

    Goisis M, Savoldi A, Guareschi M (2011) Is hyaluronic acid gel a good option for breast augmentation? Aesthetic Plast Surg 35:134–136

    PubMed  Article  Google Scholar 

  6. 6.

    Crawford R, Shrotria S (2011) Macrolane injections for breast enhancement in undiagnosed breast malignancy: a case report. J Plast Reconstr Aesthetic Surg 64:1682–1683

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to B. Chaput.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chaput, B., De Bonnecaze, G., Chavoin, J.P. et al. France Prohibits the Use of Macrolane in Aesthetic Breast Augmentation for Reasons Similar to Criticisms of Autologous Fat Grafting to the Breast. Aesth Plast Surg 36, 1000–1001 (2012). https://doi.org/10.1007/s00266-012-9882-5

Download citation

Keywords

  • Hyaluronic Acid
  • Breast Reconstruction
  • Breast Augmentation
  • Federal Drug Administration
  • Residual Nodule